Impact Factor
3.65
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.28
1,815 total citations
h5-index
43
h5 depth signal
Cited share
63.9%
363 of 568
Total citations
1,815
Citation footprint
Metric signal
3.75
External metric anchor
Self-citation
16.5%
299 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
2,735
China
222
United States
218
South Korea
162
Germany
49
Citing Fields of Research
Cardiology
2,758
Vascular Disorders
418
Scientometrics & Research Ethics
275
Information & Library Science
195
Auto-Inflammatory Disorders
139
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
9,390
Articles tracked across the journal lifetime
Indexed publication set
568
363 cited publications
Last 12 months
317
26.4 publications/month
Open access share
87.4%
277 OA publications in the last year
Leading citing country
Japan
2,735 citing publications
Leading citing field
Cardiology
2,758 citing publications
Latest tracked publication
21 October 2026
10 recent records available
Coverage & Indexing History
v66n1, Jan. 2002-
v66n1, Jan. 2002-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Issuing & Sponsoring Bodies
Contributor
Nihon Junkanki Gakkai
Broad Categories
Cardiology
Vascular Diseases
MeSH Descriptors
Cardiovascular Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1253/circj.cj-26-0431
Open DOI
Determinants and Clinical Impact of Direct Stenting in Optical Coherence Tomography-Guided Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction ― An ATLAS-OCT Substudy ―
Background: Direct stenting (DS) is a simplified strategy for primary percutaneous coronary intervention (PCI); however, its role in the era of advanced intravascular imaging remains incompletely defined. We aimed to identify determinant...
02
DOI 10.1253/circj.cj-26-0053
Open DOI
Bayesian Real-Time Decision Support for Strategy Optimization in Chronic Total Occlusion Percutaneous Coronary Intervention
Background: Complex percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) is often prolonged, underscoring the need for timely strategy selection. Although several preprocedural scoring systems exist, they offer limi...
03
DOI 10.1253/circj.cj-26-0508
Open DOI
Prognostic Impact of Diabetes Status on Outcomes After Physiology-Guided Revascularization ― Insights From the J-PRIDE Registry ―
Background: The prognostic impact of diabetes status on outcomes after physiology-guided revascularization remains unclear. This study evaluated clinical outcomes in patients with insulin-treated diabetes (ITD), non-ITD (NITD), and witho...
04
DOI 10.1253/circj.cj-26-0451
Open DOI
Current Status and Future Directions of Cardiovascular Intensive Care in Japan: Workforce, Structure, Education, and Regional Disparities ― Report of the Japan Critical Care Cardiology Committee (J4CS) ―
Rapid population aging has increased the number of patients with severe acute cardiovascular diseases requiring intensive care. Contemporary cardiovascular intensive care has evolved beyond traditional management of acute coronary syndro...
05
DOI 10.1253/circj.cj-26-0640
Open DOI
Reduced Adverse Events Without Survival Benefit With HeartMate 3 vs. HeartMate II in Japan
Background: HeartMate 3 (Abbott Laboratories), a fully magnetically levitated left ventricular assist device (LVAD), has shown improved hemocompatibility vs. previous devices, but nationwide real-world data in Japan remain limited.Method...
06
DOI 10.1253/circj.cj-26-0268
Open DOI
High Lipoprotein(a) Is a Predictor of Adverse Events and Heart Failure in Patients With Acute Myocardial Infarction
Background: Lipoprotein(a) (Lp(a)) is a well-established risk factor for atherosclerotic cardiovascular disease, but its prognostic role after acute myocardial infarction (AMI) remains unclear. This study investigated the association bet...
07
DOI 10.1253/circj.cj-26-0575
Open DOI
Nationwide Evolution of Durable Left Ventricular Assist Device Outcomes Following Introduction of the HeartMate 3 and Destination Therapy in Japan ― The Third Official Report From J-MACS ―
Background: The nationwide impact in Japan of contemporary improvement in the clinical management of durable left ventricular assist device (LVAD), together with the introduction of the HeartMate 3 (Abbott, Pleasanton, CA, USA), on clini...
08
DOI 10.1253/circj.cj-26-0356
Open DOI
Phenotyping Heart Failure With Preserved Ejection Fraction in Japan ― Position Paper on Current Evidence and Future Directions ―
Heart failure with preserved ejection fraction (HFpEF) is rapidly increasing in Japan in parallel with population aging, rising from just over half of all heart failure cases in 2015 to approximately 54% in 2025 and projected to reach ne...
09
DOI 10.1253/circj.cj-26-0311
Open DOI
Prognostic Impact of Left Ventricular Apical Aneurysm Identified by Echocardiography in Hypertrophic Cardiomyopathy ― A Multicenter Retrospective Study in Japan ―
Background: This study evaluated the prognostic impact of left ventricular (LV) apical aneurysm identified by transthoracic echocardiography (TTE) in a Japanese cohort with hypertrophic cardiomyopathy (HCM).Methods and Results: We retros...
10
DOI 10.1253/circj.cj-26-0697
Open DOI
In-Hospital Guideline-Directed Medical Therapy Intensification and Long-Term Outcomes in Patients Hospitalized for Heart Failure in the Current Clinical Paradigm ― Insights From the QHEART-R Study ―
Background: The real-world impact of in-hospital intensification of guideline-directed medical therapy (GDMT) on clinical outcomes in patients with heart failure (HF) remains uncertain. We evaluated the association between in-hospital GD...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 83, no. 12 (Dec. 2019).
Supplements in Japanese accompany some issues.
Available also online.